Paloma Partners’s NEVRO CORP. NVRO Stock Holding History

Paloma Partners’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,000	Closed	-$84K	–	1196
2022 Q3	$84K	Buy	+25,000	New	+$1.16M	﹤0.01%	853
2022 Q2	–	Sell	-10,000	Closed	-$723K	–	1845
2022 Q1	$723K	Buy	+10,000	New	+$721K	0.02%	564

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paloma Partners's NVRO Position: Q3 2022 in Review

Paloma Partners sold out of NEVRO CORP. (NVRO) in Q3 2022, closing a stake of 20,600 shares — an estimated $956K sold.

Paloma Partners first reported a position in NVRO in Q1 2017 and held it in 10 quarters. The position peaked at $1.38M in Q3 2020. 177 funds tracked by Wall St. Rank hold NVRO as of Q3 2022.

Paloma Partners reported no remaining NEVRO CORP. position as of Q3 2022 after selling out during the quarter.
Paloma Partners sold 20,600 NEVRO CORP. shares in Q3 2022, an estimated $956K.
Paloma Partners first reported a position in NEVRO CORP. in Q1 2017 and held it in 10 quarters.
Paloma Partners's NEVRO CORP. position peaked at $1.38M in Q3 2020.
177 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2022.

Based on Paloma Partners's 13F filing for Q3 2022, filed 14 Nov 2022.